Product Name: LINGO1 antibody [C1C3]
Applications: WB
Predicted Target Size: 70 kDa (note) (13)
Positive Controls: NT2D1 , IMR32 , U87-MG , MCF-7
Form Supplied: Liquid
Concentration: 1 mg/ml (Please refer to the vial label for the specific concentration)
Purification: Purified by antigen-affinity chromatography.
Full Name: leucine rich repeat and Ig domain containing 1
Background: Functional component of the Nogo receptor signaling complex (RTN4R/NGFR) in RhoA activation responsible for some inhibition of axonal regeneration by myelin-associated factors. Is also an important negative regulator of oligodentrocyte differentiation and axonal myelination.
Synonyms: FLJ14594 antibody, LERN1 antibody, LRRN6A antibody, MGC17422 antibody, UNQ201 antibody, LINGO1 antibody, leucine rich repeat neuronal 6A antibody, leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 antibody, leucine-rich repeat neuronal protein 1 antibody, leucine-rich repeat and immunoglobilin domain-containing protein 1 antibody, leucine-rich repeat neuronal protein 6A antibody, leucine rich repeat and Ig domain containing 1 antibody
Cellular Localization: Cell membrane; Single-pass type I membrane protein
CAS NO: 1197300-24-5
Product: Pirarubicin (Hydrochloride)
Host: Rabbit
Clonality: Polyclonal
Isotype: IgG
Immunogen: Recombinant protein encompassing a sequence within the C-terminus region of human Lingo-1. The exact sequence is proprietary.
Antigen Species: Human
Species Reactivity: Human
Conjugation: Unconjugated
Storage Buffer: 1XPBS, 1% BSA, 20% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.
Storage Instruction: Keep as concentrated solution. Aliquot and store at -20ÂșC or below. Avoid multiple freeze-thaw cycles.
Notes: For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Specificity:
PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/24497846?dopt=Abstract
